Drucy S Borowitz
Overview
Explore the profile of Drucy S Borowitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
371
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Validation of an omega-3 substrate challenge absorption test as an indicator of global fat lipolysis
Freedman S, Zaworski K, Pierzynowska K, Pierzynowski S, Gallotto R, Sathe M, et al.
PLoS One
. 2023 May;
18(5):e0284651.
PMID: 37155649
Introduction: The coefficient of fat absorption (CFA) quantifies fat that remains in stool after digestion and is not a direct measure of lipolysis. CFA has been used to assess treatment...
2.
Carrion A, Borowitz D, Freedman S, Siracusa C, Goralski J, Hadjiliadis D, et al.
J Pediatr Gastroenterol Nutr
. 2017 Oct;
66(3):451-454.
PMID: 29045347
The effect of ivacaftor in patients with cystic fibrosis (CF) with recurrent pancreatitis is unknown. We conducted a multicenter retrospective study of patients with CF taking ivacaftor who had a...
3.
Ren C, Borowitz D, Gonska T, Howenstine M, Levy H, Massie J, et al.
J Pediatr
. 2017 Jan;
181S:S45-S51.e1.
PMID: 28129812
Objective: An unintended consequence of cystic fibrosis (CF) newborn screening (NBS) is the identification of infants with a positive NBS test but inconclusive diagnostic testing. These infants are classified as...
4.
Ren C, Fink A, Petren K, Borowitz D, McColley S, Sanders D, et al.
Pediatrics
. 2015 May;
135(6):e1386-92.
PMID: 25963008
Background And Objectives: Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome (CRMS) describes asymptomatic infants with a positive cystic fibrosis (CF) newborn screen (NBS) but inconclusive diagnostic testing for CF. Little...
5.
Heltshe S, Borowitz D, Leung D, Ramsey B, Mayer-Hamblett N
J Cyst Fibros
. 2014 Jun;
13(6):723-9.
PMID: 24917114
Background: CF infants often do not grow as expected which adversely affects later clinical outcomes, thus sensitive early measures of growth deficiency are important. This study compared attained growth for...
6.
Rowe S, Borowitz D, Burns J, Clancy J, Donaldson S, Retsch-Bogart G, et al.
Thorax
. 2012 Sep;
67(10):882-90.
PMID: 22960984
Cystic fibrosis (CF), the most common life-shortening genetic disorder in Caucasians, affects approximately 70 000 individuals worldwide. In 1998, the Cystic Fibrosis Foundation (CFF) launched the CF Therapeutics Development Network...
7.
Carlyle B, Borowitz D, Glick P
J Pediatr Surg
. 2012 Apr;
47(4):772-81.
PMID: 22498395
Purpose: Meconium ileus (MI) is the earliest clinical manifestation of cystic fibrosis (CF), occurring in up to 20% of patients with CF. Our aim was to review and integrate current...
8.
Flume P, Liou T, Borowitz D, Li H, Yen K, Ordonez C, et al.
Chest
. 2012 Mar;
142(3):718-724.
PMID: 22383668
Background: Ivacaftor (VX-770) is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator that was approved in the United States for the treatment of cystic fibrosis (CF) in patients ≥ 6...
9.
Aris R, Merkel P, Bachrach L, Borowitz D, Boyle M, Elkin S, et al.
J Clin Endocrinol Metab
. 2004 Dec;
90(3):1888-96.
PMID: 15613415
Cystic fibrosis (CF) is the most common genetic disease within the Caucasian population and leads to premature respiratory failure. Approximately 60,000 individuals are currently living with CF in North America...
10.
Boulanger S, Borowitz D, Fisher J, Brisseau G
J Pediatr Surg
. 2003 Jul;
38(7):1080-2.
PMID: 12861544
The authors report a case of an 11-year-old girl with a solitary, congenital pancreatic cyst and review the literature. Such cysts are very rare and typically are diagnosed in childhood....